2026-06-03T15:41:39+08:00 weekly 1.0 https://sk.neopharmhk.com/ 2026-05-19T19:12:25+08:00 weekly 0.9 https://sk.neopharmhk.com/our-services 2026-03-09T14:11:40+08:00 weekly 0.9 https://sk.neopharmhk.com/about-us 2026-05-08T17:22:15+08:00 weekly 0.9 https://sk.neopharmhk.com/contact-us 2026-03-09T14:11:40+08:00 weekly 0.9 https://sk.neopharmhk.com/inquiry 2026-03-09T14:11:40+08:00 weekly 0.9 https://sk.neopharmhk.com/newslist-1 2026-03-09T14:11:40+08:00 weekly 0.9 https://sk.neopharmhk.com/info/ 2026-04-24T11:13:34+08:00 weekly 0.9 https://sk.neopharmhk.com/products 2026-05-19T19:01:08+08:00 weekly 0.9 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/ 2026-05-19T19:01:25+08:00 weekly 0.9 https://sk.neopharmhk.com/finished-dosage-form/ 2026-05-19T19:02:10+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/antimigraine/ubrogepant-raw-material.html 2026-05-19T19:02:14+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/antimigraine/zavegepant-hydrochloride.html 2026-05-19T19:02:26+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/antimigraine/atogepant-cas-1374248-81-3.html 2026-05-19T19:02:28+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/antidiabetic/orforglipron-api.html 2026-05-19T19:02:31+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/antiinflammatory/loxoprofen-sodium-dihydrate.html 2026-05-19T19:02:31+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/antidiabetic/retatrutide-api.html 2026-05-19T19:02:43+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/analgesic/suzetrigine-api.html 2026-05-19T19:04:28+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/anticancer/abiraterone-acetate-api.html 2026-05-19T19:12:01+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/progestogen/dydrogesterone-api.html 2026-05-19T19:12:04+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/antineoplastic/afatinib-dimaleate.html 2026-05-19T19:12:06+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/antineoplastic/milrinone-powder.html 2026-05-19T19:12:06+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/targeted-drug/donidalorsen.html 2026-05-19T19:12:07+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/ophthalmology/diquafosol-sodium.html 2026-05-19T19:12:07+08:00 weekly 0.8 https://sk.neopharmhk.com/finished-dosage-form/psychoanaleptics/vortioxetine-hydrobromide-tablets.html 2026-05-19T19:12:07+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/targeted-drug/risdiplam.html 2026-05-19T19:12:08+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/medical-imaging/gadobutrol-fda.html 2026-05-19T19:12:09+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/vitamin/coenzyme-a-assay.html 2026-05-19T19:12:09+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/antineoplastic/lenalidomide-api.html 2026-05-19T19:12:10+08:00 weekly 0.8 https://sk.neopharmhk.com/finished-dosage-form/antibacterials-drugs/propofol-medium-and-long-chain-fat-emulsion.html 2026-05-19T19:12:11+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/antibacterials/sitafloxacin-fda-approval.html 2026-05-19T19:12:11+08:00 weekly 0.8 https://sk.neopharmhk.com/finished-dosage-form/ophthalmology-drugs/diquafosol-sodium-eye-drops.html 2026-05-19T19:12:12+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/medical-imaging/gadolinium-fda.html 2026-05-19T19:12:15+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/targeted-drug/nusinersen.html 2026-05-19T19:12:15+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/antineoplastic/propofol-api.html 2026-05-19T19:12:15+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/neuroprotective/citicoline-sodium-api.html 2026-05-19T19:12:15+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/genitourinary/terlipressin-fda.html 2026-05-19T19:12:15+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/antilipemic/resmetirom-api.html 2026-05-19T19:12:16+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/parkinson/levodopa-powder.html 2026-05-19T19:12:16+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/antitumor/lanreotide-api.html 2026-05-19T19:12:18+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/antidiabetic/cagrilintide-and-semaglutide.html 2026-05-19T19:12:18+08:00 weekly 0.8 https://sk.neopharmhk.com/finished-dosage-form/peptide-drugs/etelcalcetide-hydrochloride.html 2026-05-19T19:12:18+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/antidiabetic/liraglutide-api.html 2026-05-19T19:12:18+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/chronic-kidney-disease/finerenone-api.html 2026-05-19T19:12:18+08:00 weekly 0.8 https://sk.neopharmhk.com/finished-dosage-form/antivariceal-drugs/terlipressin-1-mg.html 2026-05-19T19:12:19+08:00 weekly 0.8 https://sk.neopharmhk.com/finished-dosage-form/somatostatin-drugs/lanreotide-injection.html 2026-05-19T19:12:19+08:00 weekly 0.8 https://sk.neopharmhk.com/finished-dosage-form/antiplasmodial-drugs/azunate-60-mg-injection.html 2026-05-19T19:12:19+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/antitumor/octreotide-api.html 2026-05-19T19:12:20+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/genitourinary/oxytocin.html 2026-05-19T19:12:20+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/antilipemic/inclisiran-sodium-api.html 2026-05-19T19:12:20+08:00 weekly 0.8 https://sk.neopharmhk.com/finished-dosage-form/diabetes-drugs/semaglutide-injection.html 2026-05-19T19:12:20+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/antidiabetic/semaglutide-raw-material.html 2026-05-19T19:12:20+08:00 weekly 0.8 https://sk.neopharmhk.com/finished-dosage-form/diabetes-drugs/liraglutide-injection.html 2026-05-19T19:12:21+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/genitourinary/atosiban-api.html 2026-05-19T19:12:21+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/antihypertensive/eplerenone-api.html 2026-05-19T19:12:22+08:00 weekly 0.8 https://sk.neopharmhk.com/finished-dosage-form/gastroenterological-drugs/linaclotide-capsules.html 2026-05-19T19:12:23+08:00 weekly 0.8 https://sk.neopharmhk.com/finished-dosage-form/antiosteoporosis-drugs/bonista-of-injection.html 2026-05-19T19:12:25+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/antineurotic/eplontersen-api.html 2026-05-19T19:12:25+08:00 weekly 0.8 https://sk.neopharmhk.com/finished-dosage-form/antidiabetic-drugs/tirzepatide-fda.html 2026-05-19T19:12:26+08:00 weekly 0.8 https://sk.neopharmhk.com/finished-dosage-form/oxytocics-drugs/carbetocin-vial.html 2026-05-19T19:12:27+08:00 weekly 0.8 https://sk.neopharmhk.com/finished-dosage-form/antibacterials-drugs/dexmedetomidine-hydrochloride-injection.html 2026-05-19T19:12:28+08:00 weekly 0.8 https://sk.neopharmhk.com/finished-dosage-form/peptide-drugs/glatiramer-acetate.html 2026-05-19T19:12:29+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/diabetes/epalrestat-fda.html 2026-05-19T19:12:30+08:00 weekly 0.8 https://sk.neopharmhk.com/finished-dosage-form/antiabortion-drugs/atosiban-acetate-injection.html 2026-05-19T19:12:31+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/genitourinary/carbetocin-api.html 2026-05-19T19:12:35+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/peptide/tirzepatide-api.html 2026-05-19T19:12:35+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/estrogen/estradiol-api.html 2026-05-19T19:12:42+08:00 weekly 0.8 https://sk.neopharmhk.com/finished-dosage-form/antibacterials-drugs/sitafloxacin-tablets.html 2026-05-19T19:12:45+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/antineoplastic/dexrazoxane-raw-material.html 2026-05-19T19:12:48+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/vitamin/purchase-vitamin-k2.html 2026-05-19T19:12:48+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/antioxidant/edaravone-fda.html 2026-05-19T19:12:52+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/peptide/abaloparatide-fda.html 2026-05-19T19:12:53+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/antitumor/degarelix-api.html 2026-05-19T19:12:54+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/peptide/etelcalcetide-powder.html 2026-05-19T19:12:56+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/peptide/linaclotide-api.html 2026-05-19T19:12:56+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/hepatoprotectants/ademetionine-butanedisulfonate.html 2026-05-19T19:12:58+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/peptide/ganirelix-api.html 2026-05-19T19:13:00+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/peptide/plecanatide-powder.html 2026-05-19T19:13:04+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/peptide/glatiramer-api.html 2026-05-19T21:47:11+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/analgesic/dexmedetomidine-hydrochloride.html 2026-05-19T21:47:19+08:00 weekly 0.8 https://sk.neopharmhk.com/active-pharmaceutical-ingredient/estrogen/tamoxifen-citrate-powder.html 2026-05-19T19:11:55+08:00 weekly 0.8 https://sk.neopharmhk.com/news/eu-recommendations-for-2026-2027-seasonal-flu-17879866817471488.html 2026-05-19T19:11:56+08:00 weekly 0.8 https://sk.neopharmhk.com/news/csl-slashes-revenue-projection-17879866899342336.html 2026-05-19T19:12:08+08:00 weekly 0.8 https://sk.neopharmhk.com/news/cphi-china-2026-the-definitive-hub-for-global-17879867092542464.html 2026-05-19T19:12:31+08:00 weekly 0.8 https://sk.neopharmhk.com/info/importance-of-formulation-17879867608753152.html 2026-05-19T19:12:37+08:00 weekly 0.8 https://sk.neopharmhk.com/info/application-areas-and-development-trends-of-dr-17879867550589952.html 2026-05-19T19:12:31+08:00 weekly 0.8 https://sk.neopharmhk.com/info/the-core-functions-of-drug-formulation-17879867499193344.html 2026-05-19T19:12:29+08:00 weekly 0.8 https://sk.neopharmhk.com/info/what-is-an-intermediate-17879867478893568.html 2026-05-19T19:12:25+08:00 weekly 0.8 https://sk.neopharmhk.com/info/history-of-antioxidant-development-17879867447780352.html 2026-05-19T19:12:30+08:00 weekly 0.8 https://sk.neopharmhk.com/info/pharmaceutical-formulation-development-trends-17879867436098560.html 2026-05-19T19:12:25+08:00 weekly 0.8 https://sk.neopharmhk.com/info/what-are-the-detailed-instructions-for-using-d-17879867429823488.html 2026-05-19T19:12:23+08:00 weekly 0.8 https://sk.neopharmhk.com/info/what-diseases-does-vortioxetine-hydrobromide-t-17879867419141120.html 2026-05-19T19:12:26+08:00 weekly 0.8 https://sk.neopharmhk.com/info/definition-and-importance-of-intermediates-17879867398169600.html 2026-05-19T19:12:25+08:00 weekly 0.8 https://sk.neopharmhk.com/info/current-status-and-development-trends-of-the-i-17879867391665152.html 2026-05-19T19:12:25+08:00 weekly 0.8 https://sk.neopharmhk.com/info/technical-principles-of-intermediates-17879867388470272.html 2026-05-19T19:12:26+08:00 weekly 0.8 https://sk.neopharmhk.com/info/application-scenarios-of-intermediates-17879867384013824.html 2026-05-19T19:12:25+08:00 weekly 0.8 https://sk.neopharmhk.com/info/what-are-intermediates-17879867383555072.html 2026-05-19T19:12:25+08:00 weekly 0.8 https://sk.neopharmhk.com/info/dexmedetomidine-hydrochloride-injection-dosage-17879867378541568.html 2026-04-22T09:45:47+08:00 weekly 0.8 https://sk.neopharmhk.com/info/is-sitafloxacin-a-cephalosporin-17879867363959808.html 2026-05-19T19:12:38+08:00 weekly 0.8 https://sk.neopharmhk.com/info/principles-of-antimicrobial-drug-use-17879867350328320.html 2026-05-19T19:12:22+08:00 weekly 0.8 https://sk.neopharmhk.com/info/in-what-situations-are-prophylactic-antibiotic-17879867340710912.html 2026-05-19T19:12:23+08:00 weekly 0.8 https://sk.neopharmhk.com/info/how-to-take-vortioxetine-hydrobromide-tablets-17879867336254464.html 2026-05-19T19:12:35+08:00 weekly 0.8 https://sk.neopharmhk.com/info/how-to-properly-store-antibiotics-17879867328832512.html 2026-05-19T19:12:36+08:00 weekly 0.8 https://sk.neopharmhk.com/info/composition-and-structure-of-antibacterial-age-17879867325621248.html